WALPAR Stock Overview
Engages in the manufacture and trading of pharmaceutical, nutraceutical, herbal, and ayurvedic commodities. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Walpar Nutritions Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹46.00 |
| 52 Week High | ₹76.98 |
| 52 Week Low | ₹39.00 |
| Beta | -0.55 |
| 11 Month Change | -11.37% |
| 3 Month Change | -26.87% |
| 1 Year Change | -0.97% |
| 33 Year Change | 187.50% |
| 5 Year Change | n/a |
| Change since IPO | 61.40% |
Recent News & Updates
Walpar Nutritions Limited (NSE:WALPAR) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 28
Does Walpar Nutritions (NSE:WALPAR) Deserve A Spot On Your Watchlist?
Sep 07Market Might Still Lack Some Conviction On Walpar Nutritions Limited (NSE:WALPAR) Even After 26% Share Price Boost
Jul 27Recent updates
Walpar Nutritions Limited (NSE:WALPAR) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 28Does Walpar Nutritions (NSE:WALPAR) Deserve A Spot On Your Watchlist?
Sep 07Market Might Still Lack Some Conviction On Walpar Nutritions Limited (NSE:WALPAR) Even After 26% Share Price Boost
Jul 27With EPS Growth And More, Walpar Nutritions (NSE:WALPAR) Makes An Interesting Case
Feb 14Here's Why Walpar Nutritions (NSE:WALPAR) Has Caught The Eye Of Investors
Sep 18We Ran A Stock Scan For Earnings Growth And Walpar Nutritions (NSE:WALPAR) Passed With Ease
May 25If EPS Growth Is Important To You, Walpar Nutritions (NSE:WALPAR) Presents An Opportunity
Sep 29Walpar Nutritions Limited's (NSE:WALPAR) P/E Is Still On The Mark Following 26% Share Price Bounce
Jul 22Shareholder Returns
| WALPAR | IN Personal Products | IN Market | |
|---|---|---|---|
| 7D | 1.3% | -1.8% | 0.3% |
| 1Y | -1.0% | 0.9% | 27.3% |
Return vs Industry: WALPAR underperformed the Indian Personal Products industry which returned 0.9% over the past year.
Return vs Market: WALPAR underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| WALPAR volatility | |
|---|---|
| WALPAR Average Weekly Movement | 7.9% |
| Personal Products Industry Average Movement | 4.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: WALPAR's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: WALPAR's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | Kalpesh Ladhawala | www.walparnutritions.com |
Walpar Nutritions Limited engages in the manufacture and trading of pharmaceutical, nutraceutical, herbal, and ayurvedic commodities. It is also involved in the contract manufacturing of nutraceutical and herbal products; and trading of raw material used in manufacturing nutraceutical products. The company was founded in 2009 and is based in Gandhinagar, India.
Walpar Nutritions Limited Fundamentals Summary
| WALPAR fundamental statistics | |
|---|---|
| Market cap | ₹399.63m |
| Earnings (TTM) | ₹24.73m |
| Revenue (TTM) | ₹643.77m |
16.9x
P/E Ratio0.6x
P/S RatioIs WALPAR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WALPAR income statement (TTM) | |
|---|---|
| Revenue | ₹643.77m |
| Cost of Revenue | ₹502.47m |
| Gross Profit | ₹141.30m |
| Other Expenses | ₹116.58m |
| Earnings | ₹24.73m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.72 |
| Gross Margin | 21.95% |
| Net Profit Margin | 3.84% |
| Debt/Equity Ratio | 47.7% |
How did WALPAR perform over the long term?
See historical performance and comparison